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Abstract 
Background: Iran has a high incidence rate for gastric cancer among the Middle East countries. In addition to gastric 
cancer, peptic ulcer is also life-threatening; thus, investigating the prevalence of Helicobacter pylori infection and 
other risk factors are essential. The present study was aimed to assess the frequency of H. pylori and the cagA-positive 
strains in patients with gastric cancer or peptic ulcer at a teaching hospital in Qom, one of the most populated cities of 
Iran. 
Materials and Methods: The presence of H. pylori was investigated in gastric cancer and peptic ulcer biopsy 
specimens using the standard culture method. PCR analysis was performed to detect the presence of the cagA 
gene. 
Results: The frequency of H. pylori isolates among 86 investigated biopsies was 20 (23.2%). Likewise, the 
rate of H. pylori was the highest when samples were examined from patients with gastric cancer (25.8%), while 
it was 21.8% when obtained from peptic ulcer patients. The frequency of the cagA gene in H. pylori isolates 
was 9 (56.2%), as confirmed by PCR. 
Conclusion: Our results indicated that H. Pylori infection and its virulent strains are frequent and widely spread 
in Qom city. The cagA gene was present in almost half of H. pylori isolates from peptic ulcer or gastric cancer 
patients. Therefore, it is necessary to screen it in all cases with H. pylori infection for early detection of gastric 
cancer. 
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Introduction 
Helicobacter pylori is a global issue with increasing 
rates of infection in the world, especially in 
developing countries 1, 2. Infection caused by H. pylori 
leads to various gastric diseases including chronic 
gastritis, peptic ulcer, and gastric cancer3-5. Recently, 
the World Health Organization (WHO) has classified 
H. pylori as Class I carcinogen and a risk factor for 
gastric adenocarcinoma6. According to the 
epidemiological studies, more than 50% of the human 
population is infected with H. pylori, although there are 
large geographical variations7. Generally, the 
prevalence of H. pylori infection is higher in developing 
countries in comparison of developed countries7,8. 
Although infection caused by H. pylori is common 
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among people, only a small group of the infected 
population develops peptic ulcer and gastric cancer9. 
Thus, factors such as host genetic, environmental, and 
bacterial virulence factors, such as the cagA gene, are 
considered to be responsible for neoplastic 
development 9-12. Poor hygiene standards and crowded 
households are among the important environmental 
factors that are associated with an increased risk of H. 
pylori infection, and these factors are usually found 
among those living in developing countries13-15. The 
cytotoxin-associated gene A (CagA) protein is the 
most extensively studied virulence factor of H. pylori. 
Several studies showed that CagA positive strains of 
H. pylori infection developed gastric cancer16-19.  
In Iran, a high prevalence of H. pylori infections has 
been reported, more than 80% in the general 
population20. To genotypes, cagA positive H. pylori 
strains in Iranian isolates were associated with gastric 
cancer20-22. Although the prevalence of H. pylori and 
its CagA phenotype has been reported in several 
regions of Iran, but our knowledge is incomplete about 
Qom, one of the central cites of Iran. Thus, the aim of 
this study was to assess the frequency of H. pylori and 
cagA-positive strains in patients with gastric cancer or 
peptic ulcer at a teaching hospital in Qom, one of the 
most populated cities of Iran. 
Methods 
This study was conducted at a teaching hospital in 
Qom (2018-2019), Iran, from July 1 to April 20. The 
study protocol was approved by the internal review 
board of Azad University of Medical Sciences.  
Study population  
Patients who were diagnosed with gastric cancer or 
peptic ulcer, based on clinical examination, were 
consecutively included in the study. Experienced 
gastroenterologist collected three biopsy specimens 
during each endoscopy session: one sample from the 
greater curvature of the corpus and two samples from 
the antrum. Biopsy specimens for bacterial culture 
were immediately placed in transport media and 
brought to the laboratory on the day of endoscopy. 
Isolation and identification of H. pylori 
We followed the protocol of Dabiri and colleagues for 
the isolation of H. pylori, using Columbia blood agar 
supplemented with 10% horse blood, and selective 
supplement of H. pylori21. Then, we incubated the 
inoculated plates for 4 to 7 days at 37°C under 
microaerophilic conditions. The H. pylori were 
identified by its biochemical profile, such as oxidase, 
catalase, and urease reactions21. 
DNA extraction and PCR amplification 
The extraction of DNA from H. pylori isolates was 
done from freshly harvested bacterial cells. The DNA 
was extracted using the DNA Mini Kit (Bio Basic, 
Canada) according to manufacturer specifications. For 
confirmation of H. pylori isolates, PCR for 16SrRNA 
and glmM genes using specific primers was performed 
based on published papers23. 
Screening of the cagA gene was performed by a 
reaction mixture22. PCR amplification was carried out 
in a PCR system21. Sterile distilled and DNA from 
colonies of H. pylori ATCC 26695 were used as 
negative and positive controls, respectively. PCR 
product was detected by 1.5% gel electrophoresis. 
Statistical analysis  
Data were analyzed using statistical program for social 
science (SPSS) version 23.0. Qualitative data were 
expressed as frequency and percentage. 
Results 
A total of 86 biopsies were collected from patients (age 
range: 40 to 65 years) with either peptic ulcer (n=55) or 
gastric cancer (n=31). Based on the culture, the 
frequency of H. pylori among all investigated biopsies 
were 20 (23.2%). Likewise, the rate of H. pylori was the 
highest when samples were examined from patients 
with gastric cancer (25.8%), while it was 21.8% when 
obtained from peptic ulcer patients.  
In the 16 H. pylori isolates which were used for 
molecular analysis, the frequency of the cagA gene in 
all H. pylori isolates was 9 (56.2%), as confirmed by 
PCR. Patients with gastric cancer had a greater 
proportion of cagA-positive H. pylori strains than those 
with peptic ulcers (62% vs. 50%). 
Discussion 
Iran is known for the high mortality rate from gastric 
cancer in the world and digestive tract diseases are 
common20. H. pylori is one of the most important risk 
factors for gastric cancer. Therefore, we investigated 
the frequency of H. pylori and its cagA gene among 
patients with gastric diseases.  
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In the current study, the total frequency of H. pylori in 
patients with either peptic ulcer or gastric cancer was 
comparable with the reported prevalence in 
developing countries and similar to gastric cancer 
samples24,25. In this study, we investigated the 
prevalence of the cagA gene, from H. pylori-positive 
gastric cancer and peptic ulcer samples using PCR. In 
Iran, the majority of H. pylori-infected individuals are 
cagA positive strains. The prevalence lies between 
66% and 90% in different ages and geographic 
regions20. The frequency of cagA-positive H. pylori is 
90% to 95% in Asian countries, whereas it is 50% to 
60% in western developed countries24. In the current 
study, we found that 56.2% of isolates from gastric 
cancer or peptic ulcer patients were positive for cagA. 
This was relatively higher than the prevalence of 
cagA, as reported by other studies, such as 46% in 
Egyptian isolates of H. pylori26. While in other 
countries in the Middle East, the cagA gene was even 
lower in H. pylori isolates from Jordan (26%)27. 
The correlation of cagA-positive H. pylori strains with 
gastric cancer was established in some previous 
studies 28-32. However, other studies reported no 
association between cagA genotype and gastric cancer 
patients33,34. The results of different studies across 
several geographical regions support the 
unpredictability of the expression of the cagA gene of 
H. Pylori across various populations 35. The variability 
of cagA gene roles in the development of gastric 
cancer in different ethnic groups shows the effect of 
host genetics or other environmental factors that 
moderate its expression. Thus, further studies are still 
needed to explore the moderating correlation of the 
cagA gene in gastric cancer patients. 
This study had some limitations. First, we only 
obtained samples from one city in Iran. Therefore, our 
results might not be generalizable across the country. 
Second, the study population in this study came from 
peptic ulcer or gastric cancer patients; therefore, the 
specifically was not the general population. Third, an 
additional study using a large number of participants 
will be necessary to confirm our current data. Finally, 
further investigation is necessary to obtain samples 
from other regions throughout the country. 
Conclusion 
Our results indicated that H. Pylori infection and its 
virulent strains are frequent and widely spread in the 
Qom. The cagA gene was present in almost half of H. 
pylori isolates from peptic ulcer or gastric cancer 
patients. Therefore, it is necessary to screen it in all 
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